Use of covered stents to treat complex cerebrovascular diseases: Expert consensus

Yueqi Zhu1, Huaqiao Tan2, Zhongxue Wu3

  • 1Department of Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

Insights

Covered stents offer a new endovascular approach for complex cerebrovascular diseases (CCVDs), enabling arterial wall reconstruction. This expert consensus provides guidance for standardizing their clinical application.

Area of Science:

  • Endovascular neurosurgery
  • Cerebrovascular disease treatment
  • Medical device innovation

Background:

  • Complex cerebrovascular diseases (CCVDs) present significant treatment challenges.
  • Existing endovascular therapies like embolization and flow diverters have limitations.
  • Covered stents represent a novel approach focusing on arterial wall reconstruction.

Purpose of the Study:

  • To establish an expert consensus on the use of covered stents for CCVDs.
  • To summarize current outcomes and propose clinical application standards.
  • To guide individualized intraluminal reconstruction treatment strategies.

Main Methods:

  • Development of an expert consensus by leading neurointervention specialists in China.
  • Review and synthesis of clinical results from covered stent application in CCVDs.
  • Formulation of standardized recommendations for clinical practice.

Main Results:

  • Covered stents have demonstrated positive outcomes in treating thousands of CCVD patients.
  • This technique allows for intraluminal reconstruction, addressing arterial wall defects.
  • The consensus provides a framework for the standardized application of covered stents.

Conclusions:

  • Covered stent insertion is an effective endovascular treatment for CCVDs.
  • Standardization is crucial for optimizing the clinical application of this technique.
  • This consensus aims to enhance patient care through individualized treatment approaches.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
22
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
247
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
23
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K